| Similar Articles |
|---|
 |
The Motley Fool
February 8, 2005
Stephen D. Simpson |
Kyphon Developing a Backbone The small med-tech company posts a rich valuation, but growth is hot, and the market is huge.   |
The Motley Fool
May 8, 2006
Stephen D. Simpson |
A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company. |
The Motley Fool
July 26, 2006
Stephen D. Simpson |
Aspect Gives Investors Nightmares The med tech company continues to grow, but high volatility is likely to follow. |
The Motley Fool
October 19, 2005
Stephen D. Simpson |
ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note. |
The Motley Fool
May 9, 2005
Stephen D. Simpson |
Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point. |
The Motley Fool
May 5, 2006
Stephen D. Simpson |
FoxHollow-ed Out Worries about guidance may be giving investors a second crack at this med-tech stock. |
The Motley Fool
May 9, 2006
Stephen D. Simpson |
NeuroMetrix Has a Lot of Nerve Though an excellent opportunity, the med-tech's price has outpaced value for investors. |
The Motley Fool
June 9, 2005
Richard Gibbons |
Buying on Margins Profit margins are one useful tool for finding great stock values. |
The Motley Fool
May 18, 2011
Arundhati Parmar |
Quick-to-Dough? No, Not Pillsbury Flour, but Medtronic Bone Cement Medtronic's announcement that it was launching a new-and-improved bone cement conjured images of baking. |
The Motley Fool
April 20, 2006
Stephen D. Simpson |
More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter. |
The Motley Fool
August 17, 2005
David Meier |
The Power of Margins The way you think about margins can give you an investing edge. |
The Motley Fool
August 31, 2006 |
Foolish Fundamentals: Margins Margins are important, but how you use margin information is more important to your investing success. Don't stay on the surface when analyzing margins. Your portfolio will thank you for it later. |
The Motley Fool
May 25, 2006
Stephen D. Simpson |
Same Old Patterson Even deep drilling can't unearth a discount at this dental and veterinary supply distributor. What's more aggravating is having to pay this multiple for the business. |
The Motley Fool
October 31, 2005
Stephen D. Simpson |
Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so. |
The Motley Fool
February 17, 2006
Stephen D. Simpson |
AtriCure Sends Investors' Hearts Aflutter AtriCure addresses a real market, but faces a typically rocky road. But executing on a big opportunity can mean ample rewards for patient investors. |
The Motley Fool
June 30, 2006
Stephen D. Simpson |
Arrow's Erratic Flight Progress for the med-tech is still slow in coming, though market rewards have come faster. Investors, take note. |
The Motley Fool
May 4, 2006
Stephen D. Simpson |
Aspect Won't Put You to Sleep High valuation of this med-tech company all but guarantees that the stock will see some volatility. |
The Motley Fool
July 6, 2011
Arundhati Parmar |
Infuse Furor May Force Medtronic Spine Business Sale. Who Would Buy? Jettisoning the spinal business may not be easy. |
